Vasculitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Vasculitis Pipeline Drugs Analysis Report Overview
Vasculitis may occur with multiple symptoms including inflammation, fever, fatigue, weight loss, a rapid pulse, and aches and pains. Also, the damaged blood vessels affect different organs and tissues, leading to various organ disfunction-related symptoms. Vasculitis diagnosis includes imaging and physiological test.
The Vasculitis pipeline drugs market report includes an assessment of the disease epidemiology, leading marketed products, and late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for vasculitis. The report also analyzes vasculitis’s clinical and commercial landscapes, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Key Highlights in the Vasculitis Pipeline Drugs Market
The vasculitis pipeline consists of many pharmaceuticals spanning all stages of development, with nearly a quarter of drugs in their late-stage development. Some of the notable players are currently developing newer products for the treatment of vasculitis in the late-stage pipeline, with GlaxoSmithKline (GSK) being the leading sponsor in vasculitis clinical research.
Key Countries in the Vasculitis Pipeline Drugs Market
In 2022, GlobalData estimates that the highest prevalent cases of vasculitis will be in China and India. The other leading countries are the US, Brazil, Japan, Russia, and the UK.
Vasculitis Pipeline Drugs Market, by Key Countries
For more Vasculitis pipeline drugs insights, download a free report samples
Key Mechanisms of Action in the Vasculitis Pipeline Drugs Market
The key mechanisms of action in the Vasculitis pipeline drugs market are receptor agonist, enzyme inhibitor, receptor antagonist, biological factor activator, enzyme activator, and Ion channel blocker.
Vasculitis Pipeline Drugs Market, by MoA
For more MoA insights, download a free report sample
Key RoA in the Vasculitis Pipeline Drugs Market
The key routes of administration in the Vasculitis pipeline drugs market are injection, and oral.
Vasculitis Pipeline Drugs by RoA
For more RoA insights, download a free report sample
Key Molecule Types in the Vasculitis Pipeline Drugs Market
The key molecule types in the Vasculitis pipeline drugs market are Biologic, Small Molecule, and Oligonucleotide.
Vasculitis Pipeline Drugs by Molecule Types
For more molecule type insights, download a free report sample
Key Companies in the Vasculitis Pipeline Drugs Market
The current vasculitis market is also dominated by some companies who are marketing genericized conventional anti-inflammatory therapies and intravenous immunoglobulins, which provide significant competition to the current top market players. Some of the key companies in the Vasculitis pipeline drugs market are Roche, GlaxoSmithKline, Bayer, Mitsubishi Tanabe, AbbVie, Amgen, Johnson & Johnson and Novartis among others. GSK is likely to emerge as an important player in vasculitis with two products currently being developed in the late-stage pipeline.
Market Report Overview
Key Countries | China, India, US, Brazil, Japan, Russia, and the UK |
Key MoA | Receptor Agonist, Enzyme Inhibitor, Receptor Antagonist, Biological Factor Activator, Enzyme Activator, and Ion Channel Blocker |
Key RoA | Injection, and Oral |
Key Molecule Types | Biologic, Small Molecule, and Oligonucleotide
|
Key Companies | Roche, GlaxoSmithKline, Bayer, Mitsubishi Tanabe, AbbVie, Amgen, Johnson & Johnson and Novartis |
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Vasculitis market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Vasculitis market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which countries are estimated to have the highest prevalent cases of vasculitis in 2022?
China and India are the countries with the highest number of prevalent cases of Vasculitis in 2022.
-
What are the key mechanisms of action in the Vasculitis pipeline drugs market?
The key mechanisms of action in the Vasculitis pipeline drugs market are receptor agonist, enzyme inhibitor, receptor antagonist, biological factor activator, enzyme activator, and Ion channel blocker.
-
What are the key routes of administration in the Vasculitis pipeline drugs market?
The key RoA in the Vasculitis pipeline drugs market are injection, and oral.
-
What are the key molecule types in the Vasculitis pipeline drugs market?
The Vasculitis pipeline drugs are classified into biologic, small Molecule and oligonucleotide based on the molecule type.
-
What are the key companies in the Vasculitis pipeline drugs market?
Some of the key companies in the Vasculitis pipeline drugs market are Roche, GlaxoSmithKline, Bayer, Mitsubishi Tanabe, AbbVie, Amgen, Johnson & Johnson and Novartis among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.